Related Experiment Video
Updated: Sep 6, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
A gene expression biomarker identifies inhibitors of two classes of epigenome effectors in a human microarray
J Christopher Corton1, Jie Liu1, Andrew Williams2
1Center for Computational Toxicology and Exposure, US Environmental Protection Agency, Research Triangle Park, NC, 27711, USA.
Abstract:
Biomarkers predictive of molecular and toxicological effects are needed to interpret emerging high-throughput transcriptomics (HTTr) data streams. To address the limited approaches available for identifying epigenotoxicants, we previously developed and validated an 81-gene biomarker that accurately predicts histone deacetylase inhibition (HDACi) in transcript profiles derived from chemically-treated TK6 cells. In the present study, we sought to determine if this biomarker (TGx-HDACi) could be used to identify HDACi chemicals in other cell lines using the Running Fisher correlation test. Using microarray comparisons derived from human cells exposed to HDACi, we found considerable heterogeneity in correlation with the TGx-HDACi biomarker dependent on chemical exposure conditions and tissue from which the cell line was derived. Using a defined set of conditions that overlapped with our earlier study, the biomarker was able to accurately identify HDACi chemicals (90-100% balanced accuracy). In an in silico screen of 2427 chemicals in 9660 chemical versus control comparisons, the biomarker coupled with the Running Fisher test was able to identify 14 additional HDACi chemicals as well as other chemicals not previously associated with HDACi. Most notable were 12 inhibitors of bromodomain (BRD) and extraterminal (BET) family proteins including BRD4 that bind to acetylated histones. The BET protein inhibitors could be distinguished from the HDACi based on differences in the expression of a small set of biomarker genes. Our results indicate that the TGx-HDACi biomarker will be useful for identifying inhibitors of two classes of epigenome effectors in HTTr screening studies.
Insights
A new biomarker accurately identifies histone deacetylase inhibitors (HDACi) in high-throughput transcriptomics data. This epigenetics biomarker also detects bromodomain and extraterminal (BET) protein inhibitors, expanding its utility in toxicological screening.
Area of Science:
- Toxicogenomics
- Epigenetics
- Biomarker Development
Background:
- High-throughput transcriptomics (HTTr) data requires robust biomarkers for interpreting molecular and toxicological effects.
- Identifying epigenotoxicants is challenging due to limited available approaches.
- An 81-gene biomarker (TGx-HDACi) was previously developed to predict histone deacetylase inhibition (HDACi) in TK6 cells.
Purpose of the Study:
- To evaluate the TGx-HDACi biomarker's ability to identify HDACi chemicals in diverse cell lines using the Running Fisher correlation test.
- To assess the biomarker's performance across different chemical exposure conditions and cell line origins.
- To screen a large chemical library for novel HDACi and other epigenome-modulating compounds.
Main Methods:
- Application of the TGx-HDACi biomarker and Running Fisher correlation test to microarray data from human cells exposed to HDACi.
- Validation of biomarker performance under defined conditions overlapping with previous studies.
- In silico screening of 2427 chemicals against 9660 chemical versus control comparisons.
Main Results:
- Considerable heterogeneity was observed in biomarker correlation based on cell line and exposure conditions.
- Under defined conditions, the biomarker accurately identified HDACi chemicals with 90-100% balanced accuracy.
- The screen identified 14 additional HDACi chemicals and 12 bromodomain and extraterminal (BET) protein inhibitors, including BRD4 inhibitors.
- BET protein inhibitors were distinguishable from HDACi by specific biomarker gene expression patterns.
Conclusions:
- The TGx-HDACi biomarker is effective for identifying HDACi across different cell lines, though performance varies with conditions.
- The biomarker successfully identified novel HDACi and BET protein inhibitors in a large-scale in silico screen.
- TGx-HDACi is a valuable tool for identifying inhibitors of both HDAC and BET epigenetic effector classes in HTTr screening studies.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
DNA Microarrays
Epigenetic Regulation
X-chromosome...
MicroRNAs

